|
gptkbp:instanceOf
|
gptkb:drug
|
|
gptkbp:approvedBy
|
gptkb:FDA
1998
|
|
gptkbp:ATCCode
|
gptkb:N06BA07
|
|
gptkbp:availableOn
|
gptkb:tablet
|
|
gptkbp:brand
|
gptkb:modafinil
|
|
gptkbp:CASNumber
|
gptkb:68693-11-8
|
|
gptkbp:chemicalFormula
|
gptkb:C15H15NO2S
|
|
gptkbp:contraindication
|
hypersensitivity to modafinil
|
|
gptkbp:controlledSubstanceSchedule
|
Schedule IV (US)
|
|
gptkbp:discoveredBy
|
gptkb:Michel_Jouvet
Laboratoires Lafon
|
|
gptkbp:drugClass
|
eugeroic
|
|
gptkbp:eliminationHalfLife
|
12-15 hours
|
|
gptkbp:excretion
|
urine
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Provigil
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:manufacturer
|
gptkb:Cephalon
|
|
gptkbp:mechanismOfAction
|
wakefulness-promoting agent
|
|
gptkbp:metabolism
|
liver
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:routeOfAdministration
|
oral
|
|
gptkbp:sideEffect
|
nausea
anxiety
headache
nervousness
insomnia
|
|
gptkbp:synonym
|
gptkb:modafinil
|
|
gptkbp:usedFor
|
gptkb:shift_work_sleep_disorder
narcolepsy
obstructive sleep apnea
|
|
gptkbp:bfsParent
|
gptkb:Cephalon
gptkb:Modafinil
|
|
gptkbp:bfsLayer
|
7
|